SEC Form 4 · accession 0001104659-18-040492
OCULAR THERAPEUTIX, INC · OCUL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jaswinder Chadha
Director
Period of report
Jun 14, 2018
Accepted (ET)
Jun 15, 2018 · 5:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001393434
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $8.14 | Jun 14, 2018 | A | 18,000 | A | — | Jun 13, 2028 | Common Stock | 18,000 | 18,000 | D |
Explanation of responses
- F1Vests with respect to 100% of the securities on the first anniversary of the grant date.
Remarks
Exhibit List Exhibit 24.1 - Power of Attorney